Christopher M Starr
Director at Monopar Therapeutics (MNPR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $659K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 5SEC | MNPRMonopar Therapeutics | Sell Plan | 4,6318,942 held (−34%) | $78.09 | $362K | -11.3% |
| Oct 5SEC | MNPRMonopar Therapeutics | Sell Plan | 2,9705,972 held (−33%) | $78.82 | $234K | -12.1% |
| Oct 5SEC | MNPRMonopar Therapeutics | Sell Plan | 7995,173 held (−13%) | $79.67 | $64K | -13.1% |
- Sell
Director Christopher M Starr sold $362K of MNPR at $78.09 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher M Starr sold $234K of MNPR at $78.82 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher M Starr sold $64K of MNPR at $79.67 — pre-scheduled 10b5-1 plan sale.